Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 13-19 , 15 July 2004

High-dose, frequently administered interferon beta therapy for relapsing–remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study

Received 23 July 2003 ,Revised 19 March 2004 ,Accepted 20 March 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0022-510X(04)00091-7

doi: 10.1016/j.jns.2004.03.023

Journal of the Neurological Sciences
Volume 222, Issue 1 , Pages 13-19 , 15 July 2004

Article Tools

* Image Usage & Resolution